Clinical trials: Gynaecological Cancer
Gynaecological Cancers
GYNGHER - HER2 Expression in Gynecological Malignancies: a Brazilian Cohort
Adult patients with gynecologic cancer (endometrial, ovarian, cervical, vulvar and vaginal cancers) treated at Oncoclínicas \& CO sites will be enrolled for primary tumor immunohistochemistry (IHC) analysis.
- Trial name
- GYNGHER (NCT07101081)
- Testing
- HER-2 Test
- Where
- Brazil
- Volunteers
- 350 people
- Sponsor
- AstraZeneca
Gynaecological Malignancies
A Study of SHR-A1811 in Subjects With Gynaecologic Oncology
This is an open-label, two-part study to evaluate the safety and efficacy of SHR-A1811 for injection in subjects with a gynaecological malignancies.
- Trial name
- NCT05896020
- Testing
- SHR- A1811
- Where
- China
- Volunteers
- 225 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.